Literature DB >> 22048452

TIM polymorphisms--genetics and function.

J Lee1, B Phong, A M Egloff, L P Kane.   

Abstract

The transmembrane immunoglobulin and mucin domain (TIM) family was identified more than a decade ago. Although the founding member of the family was first described in a rat model of ischemia-reperfusion injury, much of the recent interest in the TIM family members has focused on their potential roles in immunity. There are now a large number of genetic studies that have investigated the possible association of various TIM1 and TIM3 polymorphisms with different diseases. Here, we review this body of literature, and highlight some of the most interesting studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048452      PMCID: PMC3281969          DOI: 10.1038/gene.2011.75

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  54 in total

Review 1.  Immune regulation by the TIM gene family.

Authors:  Anjali J de Souza; Lawrence P Kane
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

3.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Authors:  G Kaplan; A Totsuka; P Thompson; T Akatsuka; Y Moritsugu; S M Feinstone
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

5.  The polymorphisms of Tim-1 promoter region are associated with rheumatoid arthritis in a Korean population.

Authors:  Soo-Cheon Chae; Young-Ran Park; Ju-Hee Song; Seung-Cheol Shim; Kyung-Sik Yoon; Hun-Taeg Chung
Journal:  Immunogenetics       Date:  2004-11-23       Impact factor: 2.846

Review 6.  Costimulation, coinhibition and cancer.

Authors:  Brant A Inman; Xavier Frigola; Haidong Dong; Eugene D Kwon
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

7.  Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand.

Authors:  P Nuchnoi; J Ohashi; R Kimura; H Hananantachai; I Naka; S Krudsood; S Looareesuwan; K Tokunaga; J Patarapotikul
Journal:  Ann Hum Genet       Date:  2008-02-19       Impact factor: 1.670

Review 8.  The TIM gene family: emerging roles in immunity and disease.

Authors:  Vijay K Kuchroo; Dale T Umetsu; Rosemarie H DeKruyff; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

9.  Association analysis of TIM-1 -232G > A and 5383_5397 insertion/deletion polymorphisms with childhood asthma and total serum immunoglobulin E levels in middle China.

Authors:  Q Wu; L Hu; P Cai; Y Li; F Chen; L Kong
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

10.  Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo.

Authors:  Jennifer Kearley; Sarah J McMillan; Clare M Lloyd
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

View more
  18 in total

1.  Soluble costimulatory molecule sTim3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion.

Authors:  Mengru Wu; Yuejie Zhu; Jing Zhao; Haiquan Ai; Qiaoqiao Gong; Jia Zhang; Junda Zhao; Qingli Wang; Xiaoling La; Jianbing Ding
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Checkpoint Inhibitors: Applications for Autoimmunity.

Authors:  Anna S Tocheva; Adam Mor
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-27       Impact factor: 4.806

3.  Protective association of TIM1-1454G>a polymorphism with asthma in a North Indian population.

Authors:  Shweta Sinha; Jagtar Singh; Surinder Kumar Jindal
Journal:  Lung       Date:  2014-10-21       Impact factor: 2.584

4.  Stimulation of Camel Polyclonal Antibody against Human T cell Immunoglobulin and Mucin 3.

Authors:  Vida Homayouni; Hossein Khanahmad; Mazdak Ganjalikhani-Hakemi; Mahdi Behdani; Pouria Ghasemi; Abbas Rezaei
Journal:  Iran J Biotechnol       Date:  2017-09-27       Impact factor: 1.671

Review 5.  Targeting novel inhibitory receptors in cancer immunotherapy.

Authors:  Quan-Quan Ding; Joe-Marc Chauvin; Hassane M Zarour
Journal:  Semin Immunol       Date:  2020-12-04       Impact factor: 11.130

Review 6.  Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.

Authors:  Shaheen Khan; David E Gerber
Journal:  Semin Cancer Biol       Date:  2019-07-19       Impact factor: 15.707

7.  KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation.

Authors:  Craig R Brooks; Melissa Y Yeung; Yang S Brooks; Hui Chen; Takaharu Ichimura; Joel M Henderson; Joseph V Bonventre
Journal:  EMBO J       Date:  2015-08-17       Impact factor: 11.598

8.  Characterizing functional domains for TIM-mediated enveloped virus entry.

Authors:  Sven Moller-Tank; Lorraine M Albritton; Paul D Rennert; Wendy Maury
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

9.  Advantages of Molecular Weight Identification during Native MS Screening.

Authors:  Ahad Khan; Anne Bresnick; Sean Cahill; Mark Girvin; Steve Almo; Ronald Quinn
Journal:  Planta Med       Date:  2018-05-09       Impact factor: 3.352

10.  Association between TIM-3 polymorphisms and cancer risk: a meta-analysis.

Authors:  Hongyan Fang; Cheng Yuan; Xinsheng Gu; Qiuju Chen; Dong Huang; Heng Li; Min Sun
Journal:  Ann Transl Med       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.